Trial recruitment is speedier in France
This article was originally published in Scrip
Executive Summary
Leem, the French pharmaceutical industry association, has revealed three trends in the recruitment of patients for clinical trials in the country: more, faster and better. Its fourth biennial survey of international Phase II and III trials carried out at least partially in France in 2006 and 2007 shows that the country has become more attractive for trial sponsors, but also that it is struggling to keep up with its European neighbours.